Safi Biotherapeutics Inc | $5,000,000 | (Sep 13, 2024)
Cavela | $2,000,000 | (Sep 13, 2024)
AceUp | $22,500,000 | (Sep 13, 2024)
Certified by Founder
Lodge
Ancilia Biosciences
start up
United States
- New York, New York
- 29/08/2024
- Unknown
- $4,200,000
Ancilia is harnessing the natural power of CRISPR to develop a new class of bacterial therapies and products for a range of applications.
- Industry Biotechnology
- Website https://www.anciliabio.com/
- LinkedIn https://www.linkedin.com/company/ancilia/
Inflammatix, Inc. | $57,000,000 | (Sep 13, 2024)
xMap | Undisclosed Amount | (Sep 13, 2024)
Gestalt | $5,900,000 | (Sep 13, 2024)
Jus Mundi | $22,000,000 | (Sep 13, 2024)
Realm.Security, Inc | $5,000,000 | (Sep 13, 2024)
PathPresenter | $7,500,000 | (Sep 13, 2024)
F2G | $100,000,000 | (Sep 13, 2024)
Ucaneo | $7,475,895 | (Sep 13, 2024)
Cohora | $2,500,000 | (Sep 13, 2024)
Reshape Automation | $5,000,000 | (Sep 13, 2024)